Intellectual property, regulations, and attorney fees
Boston, an area of 124 square kilometres has a remarkably large number of attorney firms with new firms established frequently. One would wonder how so many lawyers could be established in such a small space and still be profitable, but when one looks deeper into the Boston biotech ecosystem, the reasons become rather obvious. This is because in an area of just over 124 square kilometres, there are at least 900+ companies with some big brands such as Vertex established here.
Introduction: A view into the Boston Biotech and Biomedical Landscape
The SANBio–BioFISA II Programme is fortunate to have female project leaders supervising some of the grants in their funding portfolio. In this profile we focus on Khilona Radia, the co-founder of Antrum Biotech, a University of Cape Town spin-off specialising in Healthcare Innovation.
In the 21st century many women have really used their strength and capabilities to fill a much-needed gap in Business/Science. One of these remarkable women is Dr Nomusa Rhoda Dlamini. Dr Dlamini is a Principal Researcher in Food Sciences at CSIR Biosciences. She has extensive experience in the food and agro-processing sector and has participated in technology transfer and training. She has several publications in regional and international peer reviewed journals, and she has also presented at international conferences.
NEPAD SANBio, with support from the BioFISA II Programme, hosted their Annual Event on 21-22 February 2017 at the OR Tambo Conference Centre in Boksburg, South Africa. The theme of the event was Business meets Biosciences.
An acceleration programme aimed at supporting women in biosciences was launched on 21 February 2017, during the SANBio Annual Event 2017, by the NEPAD Southern Africa Network for Biosciences (SANBio) with support from the BioFISA II programme.
SANBio is a platform for shared biosciences research, development and innovation to address health and nutrition issues of Southern Africa and it is hosted by the Council for Scientific and Industrial Research (CSIR) in South Africa.
The BioFISA II Steering Committee conducted a site visit on 17 January 2017 to familiarise themselves with two funded projects. The purpose of the visit was to gain more insight on the "story behind the numbers" with regard to progress made and to develop a sense of joint responsibility and collaboration among the key stakeholders of the programme.
A project receiving funding from the NEPAD Southern Africa Network for Biosciences / BioFISA II Programme, entitled Gene Dose EFV was awarded the 1st place award in GAP Biosciences/Medical Innovations at the recent Gauteng Acceleration Programme (GAP) event which was held in South Africa Gauteng on 17 November 2016.
Dear Fellow Science Enthusiasts
I am very much honoured to be appointed by the Southern Africa Network for Biosciences (SANBio) to be their Student Ambassador for Lesotho.
This article is courtesy of our SANBio Student Ambassador for Zimbabwe, Joyce Fati Masvaya, who was the first person to complete the course, offered by BioFISA II, on Innovation Readiness.